Skip to main content

The .gov means it's official. Official North Dakota websites will end in .gov. Before sharing sensitive information, make sure you're on a government site.

The site is secure. The https:// ensures that you're connecting to the official website and that any information you provide is encrypted and sent securely.

Automatic translation disclaimer

The State of North Dakota provides automatic translation for nd.gov websites, courtesy of Google Translate. Please remember that the English language version is considered the most accurate. In the event of a disagreement or discrepancy between the translation and the original English version of this website or any notice or disclaimer, the original version will prevail.

North Dakota Insurance and Securities Department logo
SecuritiesState Fire MarshalEmail Updates
988
Visit 988 Suicide and Crisis Lifeline (opens in a new tab)
Main navigation
  • Home
  • About Us
    • What We Do
    • Commissioner Jon Godfread
    • News
    • Careers
    • Employee Directory
    • Contact Us
  • Consumers
    • Insurance
    • Fraud
    • Medicare
    • Prescription Connection
    • Complaints
    • Company Information
    • Other Resources
  • Producers
    • Cybersecurity Reporting
    • Resident Producer
    • Non-resident Producer
    • Business Entity
    • Continuing Education
    • Training
    • Other Licenses
    • Fee Information
    • Appointments
    • Crop Insurers
    • Veteran Licensing Exam Fee Reimbursement
    • Producer FAQ
    • Value Added Services/Rebates
    • Print License
    • Update Name/Address/Email
  • Companies
    • Company Licensing
    • Company Reporting Forms
    • Company Producer Appointments
    • Financial Reporting and Tax Requirements
    • Long-term Care Partnership Program
    • Policy, Form and Rate Filing
    • Service of Process Information
    • Value Added Services/Rebates
    • Cybersecurity Reporting
    • Reinsurance Association of North Dakota
  • Prescription Drug Cost Transparency
    • Filed Disclosure Reports
    • Information for Insurers
    • Information for Manufacturers
    • Information for Pharmacy Benefit Managers
  • Tools & Legal
    • Bulletins
    • Proposed Rulemaking
    • Enforcement
    • Studies and Reports
    • Forms
    • Insurance Company Abstract Search
    • Market Conduct Examinations
    • Public Hearings & Meetings
    • Red Tape Reduction
Main navigation Mobile
Main Menu
  • Home
  • About Us
    About Us
    • What We Do
    • Commissioner Jon Godfread
    • News
    • Careers
    • Employee Directory
    • Contact Us
  • Consumers
    Consumers
    • Insurance
    • Fraud
      Fraud
      • Report Fraud
    • Medicare
      Medicare
      • Medicare Supplement
        Medicare Supplement
        • Medicare Supplement FAQ
        • Medicare Supplement Plan Comparison
      • Medicare Advantage Plans
      • Medicare Part D
        Medicare Part D
        • Medicare Part D Open Enrollment
      • Medicare Financial Assistance Programs
      • Other Resources for Seniors
      • SHIP Counselors
    • Prescription Connection
    • Complaints
    • Company Information
      Company Information
      • Complaint and Financial Information
      • Domestic Company List and Financial Exams
      • Company Rating Services
    • Other Resources
      Other Resources
      • Air Ambulance
      • Credit Scores and Insurance
      • Loss History Reports
      • No Surprises Act
  • Producers
    Producers
    • Cybersecurity Reporting
    • Resident Producer
    • Non-resident Producer
    • Business Entity
    • Continuing Education
    • Training
    • Other Licenses
      Other Licenses
      • Auto/Car Rental
      • Bail Bond
      • Consultants
      • Life Settlements
      • Managing General Agent
      • Pharmacy Benefits Manager
      • Portable Electronics Insurance
      • Public Adjuster
      • Surplus Lines
      • Third Party Administrator
      • Title Licensing
    • Fee Information
    • Appointments
    • Crop Insurers
    • Veteran Licensing Exam Fee Reimbursement
    • Producer FAQ
    • Value Added Services/Rebates
    • Print License
    • Update Name/Address/Email
  • Companies
    Companies
    • Company Licensing
      Company Licensing
      • Accredited Reinsurer Application
      • Admitted and Authorized Reinsurers
      • Certificate of Authority Amendments
      • Certified Reinsurers
      • Discount Plan Organization
      • Filing Requirements for Licensed Companies
      • Filing Requirements for Registered and Other Entities
      • Gift Annuities
      • Insurers Uniform Application (UCAA)
      • Multiple Employer Welfare Arrangements (MEWAs)
      • Organizations or Joint Underwriters
      • Premium Finance Company
      • Prepaid Legal Services
      • Purchasing Group Application
      • Reciprocal Jurisdiction Reinsurers
      • Reinsurance Intermediary
      • Risk Retention Group Application
      • Schedule of Company Fees, Taxes and Deposits
      • Self-insurers
      • Surplus Lines Application
      • Trusteed Reinsurer Application
      • Utilization Review Agent
      • Voluntary Withdrawal
    • Company Reporting Forms
    • Company Producer Appointments
    • Financial Reporting and Tax Requirements
    • Long-term Care Partnership Program
    • Policy, Form and Rate Filing
    • Service of Process Information
    • Value Added Services/Rebates
    • Cybersecurity Reporting
    • Reinsurance Association of North Dakota
  • Prescription Drug Cost Transparency
    Prescription Drug Cost Transparency
    • Filed Disclosure Reports
      Filed Disclosure Reports
      • Drug Manufacturer's Price Disclosure Reports
      • Drug Manufacturer's Price Increase Reports
      • Drug Manufacturer's New Drug Disclosure Reports
    • Information for Insurers
    • Information for Manufacturers
    • Information for Pharmacy Benefit Managers
  • Tools & Legal
    Tools & Legal
    • Bulletins
    • Proposed Rulemaking
      Proposed Rulemaking
      • Notices of Proposed Rulemaking
    • Enforcement
    • Studies and Reports
    • Forms
    • Insurance Company Abstract Search
    • Market Conduct Examinations
    • Public Hearings & Meetings
      Public Hearings & Meetings
      • Public Hearings Archive
    • Red Tape Reduction
  • SecuritiesState Fire MarshalEmail Updates
    988
    Suicide & Crisis
    Lifeline
  • Prescription Drug Cost Transparency
    • Filed Disclosure Reports
      • Drug Manufacturer's Price Disclosure Reports
      • Drug Manufacturer's Price Increase Reports
      • Drug Manufacturer's New Drug Disclosure Reports
    • Information for Insurers
    • Information for Manufacturers
    • Information for Pharmacy Benefit Managers
Breadcrumb
  1. Home
  2. Prescription Drug Cost Transparency
  3. Filed Disclosure Reports
  4. Drug Manufacturer's 2021 New Drug Disclosure Reports

Drug Manufacturer's 2021 New Drug Disclosure Reports

Hikma Pharmaceuticals USA New Drug 8/30/2021
CLICK NAME TO DOWNLOAD DISCLOSURE REPORT
  • Hikma Pharmaceuticals USA New Drug 8/30/2021
  • Sanofi New Drug 9/16/2021
  • Par Pharmaceutical 9/17/2021
  • Amneal Pharmaceuticals New Drug 9/21/2021
  • Seagen, Inc. New Drug 9/22/2021
  • Upsher-Smith Laboratories New Drug 9/22/2021
  • Takeda Pharmaceuticals America, Inc. New Drug 9/23/2021
  • Progenics Pharmaceuticals New Drug 9/24/2021
  • Albireo Pharma Inc New Drug 9/29/2021
  • Micro Labs USA New Drug 9/30/2021
  • Biocon Pharma, Inc. New Drug 10/04/2021
  • Mylan Pharmaceuticals Inc. New Drug 10/04/2021
  • Merck Sharp & Dohme Corp. New Drug 10/06/2021
  • Pfizer Inc. New Drug 10/07/2021
  • Solaris Pharma Corp 10/12/2021
  • Zydus Pharmaceuticals (USA) Inc. 10/15/2021
  • Ascendis Pharma, Inc. 10/15/2021
  • Dr. Reddy’s Laboratories, Inc. 10/15/2021
  • Alkermes, Inc. 10/18/2021
  • Dr. Reddy’s Laboratories, Inc. 10/15/2021
  • ChemoCentryx, Inc. 10/21/2021 - Revised
  • Gilead Sciences, Inc. 10/21/2021
  • AbbVie Inc. 10/22/2021
  • Zydus Pharmaceuticals (USA) Inc. 10/26/2021
  • Padagis US LLC 10/26/2021
  • Mirum Pharmaceuticals, Inc. 10/28/2021
  • Novartis Pharmaceuticals 11/4/2021
  • Accord Healthcare, Inc. 11/5/2021
  • Meitheal Pharmaceuticals, Inc. 11/5/2021
  • Kadmon Pharmaceuticals, LLC 11/8/2021
  • Par Pharmaceutical, Inc. 11/10/2021
  • Teva Pharmaceuticals USA, Inc 11/11/2021
  • AbbVie Inc. 11/12/2021
  • Mylan Pharmaceuticals Inc. 11/18/2021
  • Zydus Pharmaceuticals (USA) Inc. 11/19/2021
  • Hikma Pharmaceuticals USA Inc. 11/22/2021
  • Mylan Pharmaceuticals Inc. 11/24/2021
  • Amneal Pharmaceuticals 11/24/2021
  • Hikma Pharmaceuticals USA Inc. 11/24/2021
  • Takeda Pharmaceuticals New Drug 11/30/2021
  • Genentech USA Inc. New Drug 12/1/2021
  • Bausch and Lomb Americas Inc New Drug 12/2/2021
  • Stratatech Corporation New Drug 12/2/2021
  • Ascend Laboratories, LLC New Drug 12/2/2021
  • Aurobindo Pharma Ltd. New Drug 12/3/2021
  • Auromedics New Drug 12/3/2021
  • Auromedics New Drug 12/3/2021
  • PharmaEssentia New Drug 12/6/2021
  • Teva Pharmaceuticals USA, Inc. New Drug 12/09/2021
  • Par Pharmaceutical, Inc. New Drug 12/13/2021
  • Zydus Pharmaceuticals (USA) Inc. New Drug 12/14/2021
  • Vgyaan Pharmaceuticals New Drug 12/14/2021
  • Teva Pharmaceuticals USA, Inc. New Drug 12/15/2021
  • Teva Pharmaceuticals USA, Inc. New Drug 12/22/2021
  • Novartis Pharmaceuticals New Drug 12/22/2021
  • Ingenus Pharmaceuticals, LLC New Drug 12/22/2021
  • argenx US Inc. 2021 New Drug 12/28/2021
  • Epic Pharma, LLC New Drug 12/29/2021
  • Eton New Drug 12/30/2021
  • Auromedics Pharmaceuticals 12/31/2021

Footer

Copyright © 2025
North Dakota Insurance & Securities Department
600 E Boulevard Ave.
Bismarck, ND 58505-0320

(701) 328-2440 | insurance@nd.gov

  • Accessibility
  • Disclaimer
  • Privacy Policy
  • Security Policy
  • Contact
  • About
  • Cybersecurity Reporting
  • Social Media Policy
Subscribe to News and Alerts
North Dakota Insurance and Securities Department logo